Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02391116
Title Phase II Copanlisib in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bayer
Indications

diffuse large B-cell lymphoma

Therapies

Copanlisib

Age Groups: adult
Covered Countries ITA | FRA | DEU | CAN | BEL


No variant requirements are available.